INmune Bio Inc. to Announce Top Line Results from MINDFuL Phase 2 Trial in Early Alzheimer’s on Monday, June 30th

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/22/2026

1. SPCX
2. NVDA
3. ACN
4. USO
5. GOOGL
6. APGE
7. DFTX
8. MU
9. IBM
10. HOOD

Go back to INmune Bio Inc. to Announce Top Line Results from MINDFuL Phase 2 Trial in Early Alzheimer’s on Monday, June 30th
(NASDAQ: INMB) Delayed: 1.43 -0.02 (1.38%)
Previous Close $1.45    52 Week High $ 
Open $1.41    52 Week Low $ 
Day High $1.48    P/E N/A 
Day Low $1.35    EPS $ 
Volume 284,421       

(NASDAQ: INMB) Delayed: 1.43 -0.02 (1.38%)
Previous Close $1.45    52 Week High $ 
Open $1.41    52 Week Low $ 
Day High $1.48    P/E N/A 
Day Low $1.35    EPS $ 
Volume 284,421